- Home
- BNTX vs WSM Comparison
BNTX vs WSM Comparison
Compare BNTX & WSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- WSM
- Stock Information
- Founded
- BNTX 2008
- WSM 1956
- Country
- BNTX Germany
- WSM United States
- Employees
- BNTX N/A
- WSM N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- WSM Home Furnishings
- Sector
- BNTX Health Care
- WSM Consumer Discretionary
- Exchange
- BNTX Nasdaq
- WSM Nasdaq
- Market Cap
- BNTX 25.0B
- WSM N/A
- IPO Year
- BNTX 2019
- WSM N/A
- Fundamental
- Price
- BNTX $107.84
- WSM $169.76
- Analyst Decision
- BNTX Strong Buy
- WSM Hold
- Analyst Count
- BNTX 18
- WSM 18
- Target Price
- BNTX $141.55
- WSM $170.06
- AVG Volume (30 Days)
- BNTX 914.5K
- WSM 1.6M
- Earning Date
- BNTX 08-04-2025
- WSM 08-21-2025
- Dividend Yield
- BNTX N/A
- WSM 1.56%
- EPS Growth
- BNTX N/A
- WSM 6.75
- EPS
- BNTX N/A
- WSM 8.66
- Revenue
- BNTX $2,968,331,171.00
- WSM $7,781,306,000.00
- Revenue This Year
- BNTX N/A
- WSM $1.35
- Revenue Next Year
- BNTX $10.68
- WSM $3.07
- P/E Ratio
- BNTX N/A
- WSM $19.53
- Revenue Growth
- BNTX 0.61
- WSM 1.64
- 52 Week Low
- BNTX $76.53
- WSM $125.33
- 52 Week High
- BNTX $131.49
- WSM $219.98
- Technical
- Relative Strength Index (RSI)
- BNTX 53.44
- WSM 58.25
- Support Level
- BNTX $102.57
- WSM $161.63
- Resistance Level
- BNTX $108.39
- WSM $165.41
- Average True Range (ATR)
- BNTX 2.66
- WSM 4.47
- MACD
- BNTX -0.22
- WSM 0.89
- Stochastic Oscillator
- BNTX 66.59
- WSM 95.57
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.